1. Home
  2. EGY vs HELP Comparison

EGY vs HELP Comparison

Compare EGY & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VAALCO Energy Inc.

EGY

VAALCO Energy Inc.

HOLD

Current Price

$5.82

Market Cap

615.4M

Sector

Energy

ML Signal

HOLD

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

N/A

Current Price

$11.59

Market Cap

712.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EGY
HELP
Founded
1985
N/A
Country
United States
Canada
Employees
281
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
615.4M
712.2M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
EGY
HELP
Price
$5.82
$11.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$7.30
$51.50
AVG Volume (30 Days)
1.2M
1.9M
Earning Date
05-07-2026
07-01-2026
Dividend Yield
3.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$359,272,000.00
N/A
Revenue This Year
$8.78
N/A
Revenue Next Year
$29.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.36
$3.76
52 Week High
$6.72
$12.05

Technical Indicators

Market Signals
Indicator
EGY
HELP
Relative Strength Index (RSI) 59.69 68.30
Support Level $5.02 $4.41
Resistance Level $5.79 N/A
Average True Range (ATR) 0.18 0.80
MACD 0.05 0.13
Stochastic Oscillator 81.14 87.44

Price Performance

Historical Comparison
EGY
HELP

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGLs). It has a diversified, African-focused portfolio of production, development, and exploration assets located in Gabon, Egypt, Cote d'Ivoire, Equatorial Guinea, and Nigeria, which are also considered its reportable operating segments. Maximum revenue is generated from the Gabon segment, which holds working interest in and operates the Etame Marin block, located offshore Gabon. The company derives all of its revenue from crude oil, natural gas, and natural gas liquids sales.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: